Marqeta Inc vs GeneDx Holdings Corp — how do they compare? Marqeta Inc trades at $17.21 (market cap $1.85B), while GeneDx Holdings Corp trades at $61.92 (market cap $1.80B). The key difference: Marqeta Inc and GeneDx Holdings Corp are close in size by market cap. Which is the better fit depends on your goals.
| MQ | WGS | |
|---|---|---|
Market Cap | $1.85B | $1.80B |
Sector | Technology | Technology |
52-Week High | $27.32 | $167.51 |
52-Week Low | $15.04 | $34.51 |
Enterprise Value | $1.15B | $1.80B |
Trailing returns across standard periods
Headquartered in Oakland, California, and founded in 2010, Marqeta provides its clients with a card-issuing platform that offers the infrastructure and tools necessary to offer digital, physical, and tokenized payment options without the need for a traditional bank. The company's open APIs are designed to allow third parties like DoorDash, Klarna, and Block to rapidly develop and deploy innovative card-based products and payment services without the need to develop the underlying technology. The company generates revenue primarily through processing and ATM fees for cards issued on its platform.
Read more on MQ →GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →